PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CEINGE-Biotecnologie Avanzate Scarl, Naples, Italy.\', \'Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy.\', \'Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Naples, Italy.\', \'Divisione di Malattie Infettive Respiratorie, Dipartimento di Malattie Infettive e Emergenze Infettive, Ospedale Cotugno, AORN dei Colli, Naples, Italy.\', \'Dipartimento di Medicina Traslazionale, Università della Campania L. Vanvitelli, Naples, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fpubh.2021.664108
?:hasPublicationType
?:journal
  • Frontiers in public health
is ?:pmid of
?:pmid
?:pmid
  • 34211953
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.769
?:rankingScore_hIndex
  • 23
is ?:relation_isRelatedTo_publication of
?:title
  • Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all